Filing Details
- Accession Number:
- 0001209191-21-003597
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-14 16:18:49
- Reporting Period:
- 2021-01-12
- Accepted Time:
- 2021-01-14 16:18:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1681682 | Endra Life Sciences Inc. | NDRA | Electromedical & Electrotherapeutic Apparatus (3845) | 260579295 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1744025 | Bertrand Renaud Maloberti | C/O Endra Life Sciences Inc. 3600 Green Court, Suite 350 Ann Arbor MI 48105 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-01-12 | 6,304 | $1.05 | 15,276 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-13 | 13,696 | $1.10 | 1,580 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents shares sold pursuant to a Rule 10b5-1 trading plan.